QuidelOrtho Corporation
QDEL Healthcare Medical Devices
QuidelOrtho Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 1.89% from fiscal 2024. In the quarter to June 2026, revenue grew 2.77%, EPS grew 63.9%, free cash flow fell 61.5% and total debt rose 10.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow QDEL
QuidelOrtho Corporation (QDEL) P/E ratio
QuidelOrtho Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 440× (December 2015) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 6.8× | (15.91%) |
| FY2021 | 8.0× | (13.99%) |
| FY2020 | 9.3× | (77.84%) |
| FY2019 | 42.2× | 70.96% |
| FY2018 | 24.7× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PRCT PROCEPT BioRobotics Corporation compare | n/m |
| AORT Artivion, Inc. compare | n/m |
| CBLL CeriBell, Inc. compare | n/m |
| BBNX Beta Bionics, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| IART Integra LifeSciences Holdings Corporation compare | n/m |
| LMRI Lumexa Imaging Holdings, Inc. compare | n/m |
| SIBN SiBone compare | n/m |
| QDEL QuidelOrtho Corporation | n/m |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)